National Institute of Allergy and Infectious Diseases

Summary

In 1887 was created National Institute of Allergy and Infectious Diseases, which is appeared as Corporate Investor. The fund was located in North America if to be more exact in United States. The main office of represented Corporate Investor is situated in the Bethesda.

Among the various public portfolio startups of the fund, we may underline BlueWillow Biologics, Nirvana Science, Inc., Rutgers Universityu2013New Brunswick Besides, a startup needs to be aged more than 20 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Education, Medical. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has specific favorite in a number of founders of portfolio startups.

The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the National Institute of Allergy and Infectious Diseases, startups are often financed by Venture Investors, VentureSouth, Perseus. The meaningful sponsors for the fund in investment in the same round are National Institutes of Health, US Department of Energy, National Science Foundation. In the next rounds fund is usually obtained by University of Michigan MINTS fund, Small Business Innovation Research, North Coast Technology Investors.

The high activity for fund was in 2019. Speaking about the real fund results, this Corporate Investor is 72 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 2-6 investment rounds annually.